|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical impact of microbiome in patients with decompensated cirrhosis显示文摘Cirrhosis is an increasing cause of morbidity and mortality. Recent studies are trying to clarify the role of microbiome in clinical exacerbation of patients with decompensated cirrhosis. Nowadays, it is accepted that patients with cirrhosis have altered salivary and enteric microbiome, characterized by the presence of dysbiosis. This altered microbiome along with small bowel bacterial overgrowth, through translocation across the gut, is associated with the development of decompensating complications. Studies have analyzed the correlation of certain bacterial families with the development of hepatic encephalopathy in cirrhotics. In general, stool and saliva dysbiosis with reduction of autochthonous bacteria in patients with cirrhosis incites changes in bacterial defenses and higher risk for bacterial infections, such as spontaneous bacterial peritonitis, and sepsis. Gut microbiome has even been associated with oncogenic pathways and under circumstances might promote the development of hepatocarcinogenesis. Lately, the existence of the oral-gutliver axis has been related with the development of decompensating events. This link between the liver and the oral cavity could be via the gut through impaired intestinal permeability that allows direct translocation of bacteria from the oral cavity to the systemic circulation. Overall, the contribution of the microbiome to pathogenesis becomes more pronounced with progressive disease and therefore may represent an important therapeutic target in the management of cirrhosis. | Theodora Oikonomou George V Papatheodoridis Michael Samarkos Ioannis Goulis Evangelos Cholongitas | 2018 | World Journal of Gastroenterology2018，24，34： | 16 |
| 2 | Detection of CD55 - and/or CD59- deficient red cell populations in patients with lymphoproliferative syndromes显示文摘 | Meletis J Terpos E Samarkos M | 2001 | Hematol J2001，2，1： | 1 |
| 3 | Recent advances in the management of ocular complications of Sj(o)gren's syndrome显示文摘 | Samarkos M Moutsopoulos HM | 2005 | Curr Allerg Asthma Rep2005，5，： | 1 |
| 4 | Detection of CD55-and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes显示文摘 | Meletis J Terpos E Samarkos M | | 0，，01： | 1 |
| 5 | Pathogenetic potential of an- tiphospholipid antibodies 显示文摘 | Vlachoyianopoulos PG Samarkos M | 2006 | Future Cardiol2006，2，3： | 1 |
| 6 | Tuber- culosis of the parotid gland: case report and literature re- view显示文摘 | Kontopoulou T Fanourgiakis P Samarkos M | 2004 | Med Mal Infect2004，34，10： | 1 |
| 7 | Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia 显示文摘 | Meletis J Terpos E Samarkos M | 2002 | Hematology2002，7，2： | 1 |
| 8 | Detection of CD55 and/or CD59 deficient red cell populations in patients with lympho proliferative syndromes显示文摘 | Meletis J Terpos E Samarkos M | | 0，，01： | 1 |
| 9 | Association of protein-losing enteropathy and cryoglobulinaemia显示文摘 | Samarkos M Vaiopoulos G Andreopoulos A | 2003 | Stand J Gasroenterol2003，38，3： | 1 |
| 10 | The role of complement in the antiphospholipid syndrome:a novel mechanism for pregnancy morbidity显示文摘 | Samarkos M Mylona E Kapsimali V | | 0，，01： | 1 |
| 11 | Detection of CD55- and/or CD59-Deficient Red Cell Populations in Patients With Plasma Cell Dyscrasias显示文摘 | John Meletis Evangelos Terpos Michalis Samarkos Christos Meletis Effie Apostolidou Veroniki Komninaka Konstantinos Korovesis Konstantinos Anargyrou Olga Benopoulou Despina Mavrogianni Eleni Variami Nora Viniou Konstantinos Konstantopoulos | 2002 | International Journal of Hematology2002，，1： | 1 |
| 12 | Detection of CD55-and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes显示文摘 | Terpos E Samarkos M | 2001 | Hematol J2001，2，1： | 1 |
| 13 | Red cells with paroxymal nocturnal hemoglobinuria-phenotype in patients with acute leukemia显示文摘 | Terpos E Samarkos M | 2002 | Hematology2002，7，2： | 1 |
| 14 | The Role of Complement in the Antiphospholipid Syndrome: A Novel Mechanism for Pregnancy Morbidity显示文摘 | hael Samarkos EleniMylona VioletaKapsimali | 2012 | Seminars in Arthritis and Rheumatism2012，42，1： | 1 |
| 15 | Henoch-Schonlein Purpura Associated with Methicillin-Resistant Staphylococcus aureus Infection显示文摘 | Christos Eftychiou Michael Samarkos Styliani Golfinopoulou Athanasios Skoutelis Aikaterini Psarra | 2006 | The American Journal of Medicine2006，，1： | 1 |
| 16 | Henoch - Schonlein purpura associated with methicillin - resistant Staphylococcus aureus infection显示文摘 | EFTYCHIOU C SAMARKOS M GOLFINOPOULOU S | 2006 | Am J Med2006，119，1： | 1 |
| 17 | The role of complement inthe antiphospholipid syndrome: a novel mechanism for pregnancymorbidity显示文摘 | Samarkos M Mylona E Kapsimali V | 2012 | Semin Arthritis Rheum2012，42，1： | 1 |
| 18 | Henoch-Schonlein purpura associated with methicillin-resistant Staphylococcus atae- us infection显示文摘 | Eftychiou C Samarkos M Golfinopoulou S | 2006 | Am J Med2006，119，1： | 1 |
| 19 | Pasteurella multocida bacteremia,spontaneous bacterial peritonitis and septic arthritis in a cirrhotic patientJ显示文摘 | Samarkos M Fanourgiakis P Nemtzas I | | 0，，04： | 1 |
| 20 | Significance of anticardiolipin and anti-132-glycoprotein Ⅰ antibodies in lupus nephritis 显示文摘 | Loizou S Samarkos M Norsworthy PJ | 2000 | Rheumatology2000，39，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员